Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.

Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ.

Clin Cancer Res. 2011 Mar 15;17(6):1502-8. doi: 10.1158/1078-0432.CCR-10-1561. Epub 2011 Jan 25.

2.

Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ.

Ann Surg Oncol. 2011 Jan;18(1):199-206. doi: 10.1245/s10434-010-1225-7. Epub 2010 Aug 18.

3.

Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Yip-Schneider MT, Carr RA, Wu H, Schmidt CM.

J Am Coll Surg. 2017 Oct;225(4):481-487. doi: 10.1016/j.jamcollsurg.2017.07.521. Epub 2017 Jul 21.

PMID:
28739154
4.

Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.

DiMaio CJ, Weis-Garcia F, Bagiella E, Tang LH, Allen PJ.

Gastrointest Endosc. 2016 Jun;83(6):1205-9. doi: 10.1016/j.gie.2015.09.020. Epub 2015 Sep 25.

5.

Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.

Kucera S, Centeno BA, Springett G, Malafa MP, Chen YA, Weber J, Klapman J.

JOP. 2012 Jul 10;13(4):409-13. doi: 10.6092/1590-8577/664.

6.

Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.

Park WG, Wu M, Bowen R, Zheng M, Fitch WL, Pai RK, Wodziak D, Visser BC, Poultsides GA, Norton JA, Banerjee S, Chen AM, Friedland S, Scott BA, Pasricha PJ, Lowe AW, Peltz G.

Gastrointest Endosc. 2013 Aug;78(2):295-302.e2. doi: 10.1016/j.gie.2013.02.037. Epub 2013 Apr 6.

7.

Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.

Takeshita A, Kimura W, Hirai I, Takasu N, Moriya T, Tezuka K, Watanabe T.

Pancreas. 2012 Jan;41(1):114-20. doi: 10.1097/MPA.0b013e318220c1fa.

PMID:
22143341
8.

Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.

Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A.

Ann Surg. 2009 Nov;250(5):754-60. doi: 10.1097/SLA.0b013e3181bd7f20.

9.

Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.

Morimatsu K, Aishima S, Yamamoto H, Hayashi A, Nakata K, Oda Y, Shindo K, Fujino M, Tanaka M, Oda Y.

Hum Pathol. 2013 Sep;44(9):1714-21. doi: 10.1016/j.humpath.2012.12.020. Epub 2013 Apr 15.

PMID:
23597774
10.

Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.

Yip-Schneider MT, Wu H, Dumas RP, Hancock BA, Agaram N, Radovich M, Schmidt CM.

J Am Coll Surg. 2014 Apr;218(4):608-17. doi: 10.1016/j.jamcollsurg.2013.12.019. Epub 2013 Dec 24.

PMID:
24491241
11.

Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.

Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.

Cancer. 2006 Jun 25;108(3):163-73.

12.

Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts.

Tun MT, Pai RK, Kwok S, Dong A, Gupta A, Visser BC, Norton JA, Poultsides GA, Banerjee S, Van Dam J, Chen AM, Friedland S, Scott BA, Verma R, Lowe AW, Park WG.

BMC Gastroenterol. 2012 Feb 14;12:15. doi: 10.1186/1471-230X-12-15.

13.

A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas.

Sinha J, Cao Z, Dai J, Tang H, Partyka K, Hostetter G, Simeone DM, Feng Z, Allen PJ, Brand RE, Haab BB.

PLoS One. 2016 Dec 19;11(12):e0167070. doi: 10.1371/journal.pone.0167070. eCollection 2016.

14.

MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.

Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.

Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.

PMID:
24280573
15.

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.

Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra A.

Clin Cancer Res. 2012 Sep 1;18(17):4713-24. doi: 10.1158/1078-0432.CCR-12-0035. Epub 2012 Jun 21.

16.

Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease.

Sadot E, Basturk O, Klimstra DS, Gönen M, Lokshin A, Do RK, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ.

Ann Surg. 2015 Dec;262(6):1102-7. doi: 10.1097/SLA.0000000000001044.

17.

Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.

Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon AM, Dal Molin M, Scarpa A, Frulloni L, Brugge WR.

J Am Coll Surg. 2015 Feb;220(2):243-53. doi: 10.1016/j.jamcollsurg.2014.11.001. Epub 2014 Nov 6. No abstract available.

18.

Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.

Correa-Gallego C, Do R, Lafemina J, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2013 Dec;20(13):4348-55. doi: 10.1245/s10434-013-3207-z. Epub 2013 Sep 18.

PMID:
24046103
19.

Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.

Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M.

Hum Pathol. 2010 Oct;41(10):1466-74. doi: 10.1016/j.humpath.2010.04.004.

PMID:
20619441
20.

Supplemental Content

Support Center